Quinn Opportunity Partners’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-29,669
Closed -$548K 230
2017
Q3
$548K Sell
29,669
-1,000
-3% -$17.3K 0.09% 140
2017
Q2
$508K Sell
30,669
-7,100
-19% -$98.8K 0.08% 112
2017
Q1
$521K Buy
37,769
+25,069
+197% +$403K 0.12% 111
2016
Q4
$241K Buy
+12,700
New +$244K 0.07% 129

Other funds holding ENTL

Quinn Opportunity Partners's ENTL Position: Q4 2017 in Review

Quinn Opportunity Partners sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 29,669 shares — an estimated $548K sold.

Quinn Opportunity Partners first reported a position in ENTL in Q4 2016 and held it in 4 quarters. The position peaked at $548K in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Quinn Opportunity Partners reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Quinn Opportunity Partners sold 29,669 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $548K.
  • Quinn Opportunity Partners first reported a position in Entellus Medical, Inc. Common Stock in Q4 2016 and held it in 4 quarters.
  • Quinn Opportunity Partners's Entellus Medical, Inc. Common Stock position peaked at $548K in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Quinn Opportunity Partners's 13F filing for Q4 2017, filed 13 Feb 2018.